Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094764337> ?p ?o ?g. }
- W2094764337 endingPage "275" @default.
- W2094764337 startingPage "268" @default.
- W2094764337 abstract "Blood-based biomarkers may be particularly useful for patient selection and prediction of treatment response for angiogenesis inhibitors. Circulating endothelial cells (CECs) and haematopoietic progenitor cells (HPCs) might have a role in tumour angiogenesis and in tumour growth. Measurement of CECs and HPCs in the blood of patients could be a simple, non-invasive way to monitor or predict responses to treatment. (VEGFR2+) CECs, (CD133+) HPCs, plasma vascular endothelial growth factor (VEGF) and erythropoietin were measured in blood from 25 non-small cell lung cancer (NSCLC) patients before and during treatment with sorafenib plus erlotinib (SO/ER). In order to assess the drug specificity of changes in CECs and HPCs, 18 patients treated with bevacizumab plus erlotinib (BV/ER) and 10 patients with erlotinib (ER) monotherapy were studied. Response was measured in all patient groups by Response Evaluation Criteria in Solid Tumors (RECIST). At day 7, SO/ER-treated patients showed a three-fold increase in CECs (P<0.0001) comparable to BV/ER-treated patients (P<0.01), and the CECs did not change with erlotinib treatment (P=0.8). At day 7, CD133+/HPCs decreased with SO/ER treatment (P<0.0001). HPC numbers did not change with either BV/ER or erlotinib. In SO/ER-treated patients pre-treatment CD133+/HPCs were significantly lower in responders (P=0.01) and pre-treatment CD133+/HPC numbers lower than the median correlated with a longer time-to-progression (TTP) (P=0.037). Pre-treatment CD133+/HPCs are a promising candidate biomarker to further explore for use in selecting NSCLC patients who might benefit from SO/ER treatment." @default.
- W2094764337 created "2016-06-24" @default.
- W2094764337 creator A5011171028 @default.
- W2094764337 creator A5016904876 @default.
- W2094764337 creator A5022897881 @default.
- W2094764337 creator A5040043918 @default.
- W2094764337 creator A5056296378 @default.
- W2094764337 creator A5080015946 @default.
- W2094764337 creator A5083354719 @default.
- W2094764337 date "2009-12-15" @default.
- W2094764337 modified "2023-10-08" @default.
- W2094764337 title "CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients" @default.
- W2094764337 cites W1965878767 @default.
- W2094764337 cites W1979485167 @default.
- W2094764337 cites W1986396848 @default.
- W2094764337 cites W2008062232 @default.
- W2094764337 cites W2009331269 @default.
- W2094764337 cites W2010069797 @default.
- W2094764337 cites W2015632272 @default.
- W2094764337 cites W2028598028 @default.
- W2094764337 cites W2035907385 @default.
- W2094764337 cites W2039035303 @default.
- W2094764337 cites W2039155298 @default.
- W2094764337 cites W2042116568 @default.
- W2094764337 cites W2044227111 @default.
- W2094764337 cites W2047508936 @default.
- W2094764337 cites W2052488548 @default.
- W2094764337 cites W2068562114 @default.
- W2094764337 cites W2069417222 @default.
- W2094764337 cites W2079441029 @default.
- W2094764337 cites W2094699577 @default.
- W2094764337 cites W2098282622 @default.
- W2094764337 cites W2098943804 @default.
- W2094764337 cites W2105941005 @default.
- W2094764337 cites W2109134893 @default.
- W2094764337 cites W2109604836 @default.
- W2094764337 cites W2110419512 @default.
- W2094764337 cites W2127209890 @default.
- W2094764337 cites W2131152859 @default.
- W2094764337 cites W2133084119 @default.
- W2094764337 cites W2137488285 @default.
- W2094764337 cites W2139248078 @default.
- W2094764337 cites W2141236760 @default.
- W2094764337 cites W2145835533 @default.
- W2094764337 cites W2147535764 @default.
- W2094764337 cites W2150568050 @default.
- W2094764337 cites W2153891955 @default.
- W2094764337 cites W2153957737 @default.
- W2094764337 cites W2153991063 @default.
- W2094764337 cites W2157445320 @default.
- W2094764337 cites W2157535532 @default.
- W2094764337 cites W2229860909 @default.
- W2094764337 cites W2245767173 @default.
- W2094764337 cites W2280729002 @default.
- W2094764337 cites W2517521286 @default.
- W2094764337 cites W2526369364 @default.
- W2094764337 cites W4252851641 @default.
- W2094764337 doi "https://doi.org/10.1038/sj.bjc.6605477" @default.
- W2094764337 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2816651" @default.
- W2094764337 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20010948" @default.
- W2094764337 hasPublicationYear "2009" @default.
- W2094764337 type Work @default.
- W2094764337 sameAs 2094764337 @default.
- W2094764337 citedByCount "27" @default.
- W2094764337 countsByYear W20947643372012 @default.
- W2094764337 countsByYear W20947643372013 @default.
- W2094764337 countsByYear W20947643372014 @default.
- W2094764337 countsByYear W20947643372015 @default.
- W2094764337 countsByYear W20947643372016 @default.
- W2094764337 countsByYear W20947643372017 @default.
- W2094764337 crossrefType "journal-article" @default.
- W2094764337 hasAuthorship W2094764337A5011171028 @default.
- W2094764337 hasAuthorship W2094764337A5016904876 @default.
- W2094764337 hasAuthorship W2094764337A5022897881 @default.
- W2094764337 hasAuthorship W2094764337A5040043918 @default.
- W2094764337 hasAuthorship W2094764337A5056296378 @default.
- W2094764337 hasAuthorship W2094764337A5080015946 @default.
- W2094764337 hasAuthorship W2094764337A5083354719 @default.
- W2094764337 hasBestOaLocation W20947643371 @default.
- W2094764337 hasConcept C121608353 @default.
- W2094764337 hasConcept C126322002 @default.
- W2094764337 hasConcept C143998085 @default.
- W2094764337 hasConcept C167734588 @default.
- W2094764337 hasConcept C201750760 @default.
- W2094764337 hasConcept C2776256026 @default.
- W2094764337 hasConcept C2776694085 @default.
- W2094764337 hasConcept C2777025900 @default.
- W2094764337 hasConcept C2777802072 @default.
- W2094764337 hasConcept C2778019345 @default.
- W2094764337 hasConcept C2778087573 @default.
- W2094764337 hasConcept C2778695046 @default.
- W2094764337 hasConcept C2779438470 @default.
- W2094764337 hasConcept C2780394083 @default.
- W2094764337 hasConcept C28328180 @default.
- W2094764337 hasConcept C502942594 @default.
- W2094764337 hasConcept C54355233 @default.
- W2094764337 hasConcept C71924100 @default.
- W2094764337 hasConcept C86803240 @default.